Jump to content

Search the Community

Showing results for tags 'diagnosis'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


  • Discussion
    • Welcome and Newly Diagnosed
    • IBS Discussion and Symptoms
    • Diarrhea predominant IBS (IBS-D)
    • Constipation predominant IBS (IBS-C)
    • IBS Diet, low FODMAP Diet and Nutrition
    • IBS Medications, Medical Foods and Fecal Microbiota Transplantation (FMT)
    • CBT, Hypnotherapy
    • Women's Health Issues
    • IBS Patient Stories
    • IBS Podcasts and Videos
    • IBS Clinical Research Trials - Participants Wanted!
    • IBS News Articles and Research Results
    • IBS Newsfeed
    • IBS X feed (formerly called Twitter)
    • Announcements
    • We Remember
  • Member Area
    • Products We Love

Find results in...

Find results that contain...

Date Created

  • Start


Last Updated

  • Start


Filter by number of...

Found 7 results

  1. An updated American College of Gastroenterology (ACG) Guideline (2021) for IBS was just published. Among the 25 recommendations for IBS from the ACG are: Serologic testing should be performed to rule out celiac disease in patients with IBS and diarrhea symptoms. Fecal calprotectin, fecal lactoferrin and C-reactive protein should be checked in patients without alarm features and with suspected symptoms of IBS and diarrhea to rule out inflammatory bowel disease Routine stool testing should not be performed for enteric pathogens in all IBS patients. Routine colonoscopy should not be performed in patients with IBS symptoms aged younger than 45 years without warning signs. A positive diagnostic strategy vs. a diagnostic strategy of exclusion should be used for patients with IBS symptoms to improve time to initiate appropriate therapy and cost-effectiveness. Do not test for food allergies and sensitivities unless patients have reproducible symptoms concerning a food allergy. Limited trial of a low fermentable oligosaccharides, disacchardies, monosaccharides, polyols (FODMAP) diet in patients with IBS to improve global symptoms. Anorectal physiology testing should be performed in patients with IBS and symptoms that may suggest a pelvic floor disorder and refractory constipation. Anti-spasmodics available in the United States should be used to treat global IBS. Peppermint may be used to provide relief of global symptoms. Mixed opioid agonists/antagonists should be used to treat global IBS-D symptoms Use of chloride channel activators and guanylate cyclase activators (Linzess / Constella) to treat global IBS with constipation symptoms. Use of rifaximin (Xifaxan) to treat global IBS with diarrhea symptoms. Gut-directed psychotherapy (CBT) be used to treat global IBS symptoms. Source(s): Healio Pubmed: PMID: 33315591
  2. Trial by Jury: Irritable Bowel Syndrome Brooks Cash, MD ; Lin Chang, MD ; William Chey, MD ; David Kunkel, MD ; Mark Pimentel, MD VIEW WEBCAST Recorded at ACG 2019 meeting in San Antonio, TX. Target Audience: This activity has been designed to meet the educational needs of gastroenterologists and other healthcare providers involved in the care of patients with irritable bowel syndrome (IBS). Educational Objectives After completing this program, participants should be better able to: Design treatment plans for patients with IBS that are aligned with current evidence-based recommendations Explain the quality of evidence, magnitude of benefit, safety, and tolerability of specific treatments for IBS Incorporate new IBS therapies effectively into clinical practice Provided by Supported by educational grants from Salix Pharmaceuticals and Shire. This program is neither sponsored nor endorsed by ACG.
  3. What motivates someone to take the step to see a healthcare professional about their digestive symptoms?
  4. IBS: Transitioning from a Syndrome to a Disease Healio Gastroenterology, July 2018 William Chey, MD, AGAF, FACG William Chey Irritable bowel syndrome is a symptom-based condition defined by the presence of abdominal pain and altered bowel habits. The clinical phenotype can be quite diverse so while all patients have pain, some patients can have problems with diarrhea, others can have problems with constipation, and still others can have a mixture of both constipation- and diarrhea-related features. IBS is a very important condition on several different levels. First is due to its prevalence. The population-based estimates in the United States reveal that around 14% or one in seven people have symptoms that would be compatible with a diagnosis of IBS. When you look at the prevalence of IBS symptoms worldwide, you come up with a very similar number although it varies from country to country. IBS: Transitioning from a Syndrome to a Disease Healio Full coverage View the full article ©2018 Healio All Rights Reserved.
  5. IBcause™ Diagnostic Test IBcause helps doctors diagnose common underlying causes (the “troublemakers”) of persistent diarrhea, including gastrointestinal (GI) pathogens (eg, bacteria, viruses, and parasites), intestinal inflammation associated with inflammatory bowel disease (IBD), bile acid malabsorption, irritable bowel syndrome (IBS), and celiac disease. It analyzes a unique combination of 20 stool and blood measures all at 1 time. By combining so many different measures in 1 convenient test, IBcause may help speed up the step-by-step diagnostic process. It also helps your doctor determine if you have more than 1 issue that could be causing your persistent diarrhea, which is not uncommon. IBcause may help your doctor: Arrive at a diagnosis faster* Start you on the right treatment plan sooner With IBcause, over 90% of acute diarrhea-causing agents can be ruled out by your doctor. Link: >> https://www.ibcause.com ©2017 Prometheus Labs, Société des Produits Nestlé S.A. Vevey, Switzerland. All rights reserved. A Nestlé Health Science Company
  6. April is IBS Awareness Month, a time to both raise awareness as to what it is like to live with IBS and a time for those who think they have IBS to seek a diagnosis and discuss treatment options with their physician. Many treatment options are available. You do not have to suffer silently alone. For IBS Awareness Month, IBS Patient is sharing their smartphone Restroom Access Card which can be used in the event that you need immediate access to a restroom. We support the initiative by Allyson Bain to make it easier for suffers to gain access to a restroom, via The Restroom Access Act. Follow these instructions to use the smart card on your smartphone: 1. On your smartphone browser (Safari on an iPhone, Chrome on Android), go to www.ibspatient.org/restroom-access-card 2. Turn your smartphone sideways after loading to see the complete restroom access card on the screen. 3. Bookmark this URL in your browser or take a picture of the screen so that you have the Restroom Access Card in your photo library.
  • Create New...